InvestorsHub Logo
Followers 3
Posts 23
Boards Moderated 0
Alias Born 07/10/2014

Re: None

Tuesday, 09/10/2019 8:30:14 AM

Tuesday, September 10, 2019 8:30:14 AM

Post# of 3203
Acadia in his pipeline has also Trofinetide own by Neuren Pharmaceuticals (ASX Australian market) and phase 3 starting before EOY for Rett Syndrome. Rights for US only for now. With the ph3 about to start soon we can receive ANN also for this and Acadia in start of 2019 has tried to negotiate with Neuren also right outside of US not joined by Neuren. Acadia could also try to bet another offer but they need more money. Interesting time
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACAD News